Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk
(marketscreener.com) - After 5 years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected t...
read more